News | May 27, 2025
Akums reports Q4 FY25 with 12.4% revenue growth
Akums invested Rs. 272 crore in capital expenditure during FY25
Akums invested Rs. 272 crore in capital expenditure during FY25
The CDMO upgrade represents a transformational step for Remedium Lifecare
PAT stood at Rs. 88 crore for Q4 FY25 as compared to Rs. 56 crore in Q4FY24, an increase of 57%
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Strengthening capabilities in Peptide Therapeutics and CDMO services
Asahi Kasei Life Science covers a broad range of bioprocess products and services
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Subscribe To Our Newsletter & Stay Updated
